Clinical Trial Update: A Study to Compare the Immunogenicity of GSK Biologicals' 10Pn-PD-DiT 4-dose Presentation to the Licensed 1-dose Synflorix™ (10Pn-PD-DiT) Vaccine When Co-administered With DTPw-combination Vaccine in Healthy Infants [Phase 3]

View source ↗

Summary

Phase 3 trial comparing immunogenicity of a 4-dose GSK pneumococcal vaccine presentation to the licensed 1-dose Synflorix when co-administered with DTPw in heal…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infections Streptococcal

Drugs mentioned

• GSK 10Pn-PD-DiT 4-dose Presentation (pneumococcal conjugate vaccine (10Pn-PD-DiT 4-dose))
• Synflorix (10-valent pneumococcal conjugate vaccine)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Infections, Streptococcal | Phase 3 | Status: COMPLETED | Results posted: 2017-03-16